Lim C.-S.Lee C.-H.Chien Y.-J.JANN-YUAN WANGLI-NA LEECHONG-JEN YUPAN-CHYR YANGHSIN-CHIH LAISu W.-J.CHIN-CHUNG SHUYu M.C.2020-07-032020-07-0320100903-1936https://scholars.lib.ntu.edu.tw/handle/123456789/508243[SDGs]SDG3acetylcysteine derivative; agar; auramine; ethambutol; fluorochrome; isoniazid; pyrazinamide; quinoline derived antiinfective agent; rhodamine; rifampicin; sodium hydroxide citrate acetylcysteine; streptomycin; unclassified drug; acid fast bacterium; adult; antibiotic resistance; antibiotic sensitivity; bacterial growth; bacterium culture; bacterium identification; bacterium isolate; blurred vision; centrifugation; controlled study; culture medium; drug treatment failure; drug withdrawal; female; fluorometry; gastrointestinal symptom; hospital bed capacity; human; letter; liver toxicity; lung tuberculosis; major clinical study; male; Mycobacterium tuberculosis; peripheral neuropathy; precipitation; prediction; priority journal; room temperature; scoring system; skin pruritus; smear; sputum analysis; sputum culture; stain; Taiwan; tertiary health care; treatment duration; treatment outcome; upper gastrointestinal bleeding; Antitubercular Agents; Bacteriological Techniques; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Sputum; Time Factors; Tuberculosis, Pulmonaryletter10.1183/09031936.00102709200444632-s2.0-75149115430